Trial intelligence / Profile preview

Testosterone replacement in hypogonadal men with type 2 diabetes

NCT00349362Phase 4Completed

Sponsor
Barnsley Hospital
Start
Jul 2006
Primary completion
Oct 2008
Modality
Device-based Delivery
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Sustanon 250 in Hypogonadism, sponsored by Barnsley Hospital. Primary endpoint: Glycated Haemoglobin at 6 months. Started Jul 2006; status: completed.

02

Drugs

Sustanon 250
03

Conditions

Hypogonadism

Beyond the preview

Go deeper on NCT00349362.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00349362.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call